Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2012
11/07/2012CN102178245B Extraction method for folium mori dietary fibers
11/07/2012CN102166293B Garlic oil navel paste and preparation method and application thereof
11/07/2012CN102040569B Carotinoid derivatives and preparation method and application thereof
11/07/2012CN102018692B PTP1B inhibitors and synthesis thereof, and application of PTP1B inhibitors in preparation of medicines for treating type 2 diabetes
11/07/2012CN102008477B Method for preparing tablet drug composition containing Rosuvastatin calcium
11/07/2012CN101928655B Schisandra chinensis health protection wine and preparation method thereof
11/07/2012CN101904869B Method for preparing animal semen freeze-dried powder
11/07/2012CN101891817B Monoclonal antibody capable of preventing high mobility group box-1 (HMGB-1) and application thereof
11/07/2012CN101879178B Medicinal application of timosaponin BIII
11/07/2012CN101878906B Health care food with auxiliary hyperglycemic function and preparation method thereof
11/07/2012CN101854931B Therapeutic composition containing amlodipine nicotinate and statins
11/07/2012CN101785781B Medicine combination of levoamlodipine or medicinal salt of levoamlodipine and auricularia auricula polysaccharide, and application thereof
11/07/2012CN101773465B Polymer micelle medicine carrying system using amino acid as stabilizing agent
11/07/2012CN101717345B Threonine chromium compound and preparation method thereof
11/07/2012CN101696386B Brewing method of highland barley monascus healthy wine
11/07/2012CN101687886B Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
11/07/2012CN101671329B Indolylmaleimide compound substituted with 3-amino alcohol, preparation method and application thereof
11/07/2012CN101637257B Food with function of regulating blood sugar and preparation method thereof
11/07/2012CN101590051B Drug combination containing nicotinic acid, HMG-CoA reductase inhibitor and alpha-glucosidase inhibitor
11/07/2012CN101541796B Novel substituted diaza spiro pyridinone derivatives for use in MCH-1 mediated diseases
11/07/2012CN101503365B Preparation of venlafaxine intermediate 1-[2-amino-1-(4-methoxy phenyl)ethyl] cyclohexanol
11/07/2012CN101491668B Composition with blood-sugar reducing function and preparation method thereof
11/07/2012CN101402583B Levorotation carnitine acid calcium phosphate, preparation method and use thereof
11/07/2012CN101268047B Crystalline and amorphous sodium atorvastatin
11/07/2012CN101264121B Blood fat reducing health products and preparation
11/07/2012CN101214373B Open-loop intelligent insulin pump control method
11/07/2012CN101193561B Dietary fiber composition comprising glucomannan, xanthan gum, and alginate
11/07/2012CN101155781B Pyridine-3-carboxamide derivatives as cb1 inverse agonists
11/07/2012CN101074223B Versulin derivative and its use in treatment of diabetes and its complication
11/07/2012CN101001837B Indole derivatives comprising an acetylene group as PPAR activators
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012US8304412 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
11/06/2012US8304411 Dicycloazaalkane derivates, preparation processes and medical uses thereof
11/06/2012US8304409 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
11/06/2012CA2493083C Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
11/06/2012CA2365532C Arpe-19 as a platform cell line for encapsulated cell-based delivery
11/01/2012WO2012149495A1 Modulation of apolipoprotein ciii (apociii) expression
11/01/2012WO2012149452A1 Compounds, formulations, and methods of protein kinase c inhibition
11/01/2012WO2012149236A1 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
11/01/2012WO2012149157A2 Heterocyclic compounds for the inhibition of pask
11/01/2012WO2012148246A2 A preparation method of sitagliptin
11/01/2012WO2012148140A2 Imidazole-based alkaloid derivatives which have angiogenesis inhibition and antioxidant effects and production method thereof
11/01/2012WO2012147853A1 Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor
11/01/2012WO2012147832A1 Phenyl pyrrole derivative crystal
11/01/2012WO2012147765A1 Benzimidazole derivative having npy y5 receptor antagonist action
11/01/2012WO2012147764A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity
11/01/2012WO2012147619A1 Blood glucose level increase inhibitor
11/01/2012WO2012147518A1 Novel 3-hydroxyisothiazole 1-oxide derivative
11/01/2012WO2012147516A1 Cyclic amide derivative
11/01/2012WO2012147351A1 Powdered starting material, bottle cap, and container comprising said bottle cap
11/01/2012WO2012147003A1 Vitamin b1 for treatment of chronic fatigue
11/01/2012WO2012146110A1 Insulin-delivering transdermal formulation and preparation method therefor
11/01/2012WO2012146075A1 Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof
11/01/2012WO2012146057A1 Curcuminoid injection solution and intravenous injection
11/01/2012WO2012145899A1 Ester compound, preparation method and application thereof
11/01/2012WO2012106584A3 Pitavastatin salts
11/01/2012US20120277317 Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-related diseases
11/01/2012US20120277315 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
11/01/2012US20120277305 Fatty acid guanidine and salicylate guanidine derivatives and their uses
11/01/2012US20120277303 Equol-containing fermentation product of soybean embryonic axis, and method for production thereof
11/01/2012US20120277294 Functional food additives
11/01/2012US20120277292 ANTISENSE OLIGONUCLEOTIDES AGAINST cPLA2, COMPOSITIONS AND USES THEREOF
11/01/2012US20120277290 Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg
11/01/2012US20120277289 Activity generating delivery molecules
11/01/2012US20120277280 Phenoxy-pyrrolidine derivative and its use and compositions
11/01/2012US20120277277 Methods of Treating a Hyperproliferative Disorder or Inhibiting Cell Growth in a Mammal
11/01/2012US20120277270 Method for Decreasing Symptoms of Alcohol Consumption
11/01/2012US20120277259 Substituted benzofused derivatives and their use as vanilloid receptor ligands
11/01/2012US20120277256 Frequency modulated drug delivery (fmdd)
11/01/2012US20120277242 Pyridin-2YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus
11/01/2012US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/01/2012US20120277228 Novel Azaheterocyclic Compounds
11/01/2012US20120277224 Heterocyclic compounds for the inhibition of pask
11/01/2012US20120277223 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/01/2012US20120277222 Treating various disorders using trkb agonists
11/01/2012US20120277219 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/01/2012US20120277215 Organic Compounds
11/01/2012US20120277212 Novel Oxime Derivatives and Their Use As Allosteric Modulators of Metabotropic Glutamate Receptors
11/01/2012US20120277209 Pyrazine compounds as phosphodiesterase 10 inhibitors
11/01/2012US20120277208 Benzamide compound
11/01/2012US20120277201 Use of hydroxyprogesterone derivatives for enhancing health and physical performance
11/01/2012US20120277196 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
11/01/2012US20120277186 Tricyclic Derivatives and Their Pharmaceutical Use and Compositions
11/01/2012US20120277179 Edible Energy Composition
11/01/2012US20120277171 Warmi®, natural alternative for the treatment of menopause
11/01/2012US20120277170 Nutritive compositions and methods of using same
11/01/2012US20120277158 Compositions and methods for the transport of therapeutic agents
11/01/2012US20120277154 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof
11/01/2012US20120277151 Glp-1 pharmaceutical compositions
11/01/2012US20120277150 Novel 3-hydroxyisothiazole 1-oxide derivative
11/01/2012US20120277149 Pharmaceutical combinations for the treatment of metabolic disorders
11/01/2012US20120277148 Insulin analogues with chlorinated amino acids
11/01/2012US20120277147 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
11/01/2012US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
11/01/2012US20120276225 Phytoestrogenic nutraceutical composition from palm leaf extract
11/01/2012US20120276215 Therapeutic Conditioned Media
11/01/2012US20120276214 Infant nutrition with protease inhibitor
11/01/2012US20120276212 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276166 Elution-stabilized preparation
1 ... 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 ... 1298